The mixed prescription of escitalopram (Lexapro) and bupropion (Wellbutrin) addresses a nuanced strategy to treating melancholy. Escitalopram, a selective serotonin reuptake inhibitor (SSRI), primarily will increase serotonin ranges within the mind. Bupropion, however, is a norepinephrine-dopamine reuptake inhibitor (NDRI), affecting norepinephrine and dopamine ranges. This twin motion may be significantly helpful when a affected person experiences incomplete reduction from melancholy with an SSRI alone. For instance, a affected person may discover that escitalopram alleviates their nervousness however leaves them feeling fatigued and missing motivation; bupropion can then be added to counteract these unwanted effects.
This therapeutic technique gives a number of potential benefits. Firstly, it broadens the spectrum of neurotransmitters focused, doubtlessly resulting in extra complete symptom reduction. Secondly, it might mitigate a few of the widespread unwanted effects related to SSRIs, equivalent to sexual dysfunction or weight achieve, that are much less continuously noticed with bupropion. Traditionally, clinicians have noticed that some sufferers reply higher to a mixed strategy than to growing the dosage of a single antidepressant. Moreover, bupropion’s stimulating properties can enhance power ranges and focus, which are sometimes impaired in people with melancholy.
